Balkan Medical Journal
Letters to the Editor

Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection

1.

Department of Hematology, University of Health Sciences, İstanbul Bakırköy Dr. Sadi Konuk Training and Research Hospital, İstanbul, Turkey

2.

Division of Hematology, Department of Internal Medicine, İstanbul University İstanbul School of Medicine, İstanbul, Turkey

3.

Department of Molecular Biology and Genetics, İstanbul University İstanbul School of Science, İstanbul, Turkey

Balkan Medical Journal 2021; 38: 141-142
DOI: 10.4274/balkanmedj.galenos.2020.2020.9.106
Read: 126 Downloads: 108 Published: 13 January 2021

Cite this article as: Hindilerden F, Yönal Hindilerden İ, Diz Küçükkaya R. Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection. Balkan Med J. 2021;38(2):141-142.

Files
ISSN 2146-3123 EISSN 2146-3131